Emerging new targets for the treatment of resistant fungal infections
N Liu, J Tu, G Dong, Y Wang… - Journal of medicinal …, 2018 - ACS Publications
With the increasing morbidity and mortality of invasive fungal infections and the emergence
of severe antifungal drug resistance, new drug targets and novel antifungal agents are …
of severe antifungal drug resistance, new drug targets and novel antifungal agents are …
Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases
IJ dos Santos Nascimento, MAT Cavalcanti… - European Journal of …, 2023 - Elsevier
Neglected tropical diseases (NTDs) constitute a group of approximately 20 infectious
diseases that mainly affect the impoverished population without basic sanitation in tropical …
diseases that mainly affect the impoverished population without basic sanitation in tropical …
Blocking myristoylation of Src inhibits its kinase activity and suppresses prostate cancer progression
Protein N-myristoylation enables localization to membranes and helps maintain protein
conformation and function. N-myristoyltransferases (NMT) catalyze co-or posttranslational …
conformation and function. N-myristoyltransferases (NMT) catalyze co-or posttranslational …
[HTML][HTML] Synthesis, antifungal activities and molecular docking studies of benzoxazole and benzothiazole derivatives
B Luo, D Li, AL Zhang, JM Gao - Molecules, 2018 - mdpi.com
Based on benzoxazole and benzothiazole scaffold as an important pharmacophore, two
series of 2-(aryloxymethyl) benzoxazole and benzothiazole derivatives were synthesized …
series of 2-(aryloxymethyl) benzoxazole and benzothiazole derivatives were synthesized …
Tetrazolylmethyl quinolines: Design, docking studies, synthesis, anticancer and antifungal analyses
SKJ Shaikh, RR Kamble, SM Somagond… - European Journal of …, 2017 - Elsevier
A new series of 2, 5 and 1, 5-regioisomers of the tetrazolyl group viz., 3-[(5-benzyl/benzylthio-
2H-tetrazol-2-yl) methyl]-2-chloro-6-substituted quinoline 6h-q and 3-[(5-benzyl/benzylthio …
2H-tetrazol-2-yl) methyl]-2-chloro-6-substituted quinoline 6h-q and 3-[(5-benzyl/benzylthio …
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
MK Fenwick, AR Reers, Y Liu, R Zigweid… - ACS Infectious …, 2023 - ACS Publications
Each year, approximately 50,000 children under 5 die as a result of diarrhea caused by
Cryptosporidium parvum, a protozoan parasite. There are currently no effective drugs or …
Cryptosporidium parvum, a protozoan parasite. There are currently no effective drugs or …
A new era for Chagas disease drug discovery?
M Keenan, JH Chaplin - Progress in medicinal chemistry, 2015 - Elsevier
Recent clinical trials investigating treatment of chronic indeterminate Chagas disease with
two re-purposed azole anti-fungal drugs, posaconazole and ravuconazole, revealed their …
two re-purposed azole anti-fungal drugs, posaconazole and ravuconazole, revealed their …
Multiple quantitative structure-activity relationships (QSARs) analysis for orally active trypanocidal N-myristoyltransferase inhibitors
VH Masand, NNE El-Sayed, MU Bambole… - Journal of Molecular …, 2019 - Elsevier
In the present work, OECD guidelines have been followed for developing QSAR
(Quantitative Structure-Activity Relationship) models for anti-HAT (Human African …
(Quantitative Structure-Activity Relationship) models for anti-HAT (Human African …
Strategies in the discovery of novel antifungal scaffolds
N Liu, C Wang, H Su, W Zhang… - Future medicinal …, 2016 - Future Science
The development of next-generation antifungal agents with novel chemical scaffolds and
new mechanisms of action is vital due to increased incidence and mortality of invasive …
new mechanisms of action is vital due to increased incidence and mortality of invasive …
[HTML][HTML] Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression
Fibroblast growth factor (FGF)/FGF receptor (FGFR) signaling facilitates tumor initiation and
progression. Although currently approved inhibitors of FGFR kinase have shown therapeutic …
progression. Although currently approved inhibitors of FGFR kinase have shown therapeutic …